Molecular characterization of avian reovirus isolates in Tunisia by unknown
Hellal Kort et al. Virology Journal 2013, 10:12
http://www.virologyj.com/content/10/1/12RESEARCH Open AccessMolecular characterization of avian reovirus
isolates in Tunisia
Ymene Hellal Kort1, Hager Bourogâa1, Latifa Gribaa1, Daniel Scott-Algara2 and Abdeljelil Ghram1*Abstract
Background: Genotype analyses of avian reoviruses isolated from organ samples collected from chickens with
suspicious clinical symptoms, between 1997–2008, was based on sequences for both σC and σB genes and aligned
with those published in the Genbank, making it possible to carry out studies of molecular classification and
relationships.
Methods: The full length of the known variable protein σC and part of the σB encoding genes, were amplified
with RT-PCR, using conserved primers. PCR products were sequenced and the sequences were analyzed and
aligned with avian reovirus sequences from the Genbank database.
Results: The sequences of σC-encoding genes of all the isolated strains indicated their close relationship with the
American, Chinese and Indian strains. Taking the American strain S1133 as a reference, the two Tunisian isolates
97.1 and 97.2 showed some nucleotide substitutions. For isolate 97.1, the substitution was silent whereas for strain
97.2 the mutation was at the first position of the corresponding codon and induced the substitution of the amino
acid encoded. For the σB-encoding gene, the sequences of the Tunisian strains showed mutations at positions two
or three of the corresponding codons, inducing substitutions of amino acids at these positions. The phylogenic
trees based on σC and σB encoding genes indicated closer relationship between Tunisian, American and Taiwanese
isolates of genotype I.
Conclusion: Our study describes the genotype of avian reoviruses that are not yet well characterized genetically.
The characterization and classification of these viruses might be significant for understanding the epidemiology of
malabsorption syndrome and viral arthritis, and improving our knowledge of the genotype of strains circulating in
Tunisian flocks. Furthermore, the study of their variable pathogenicity could be extremely important in the choice
of the appropriate vaccine strain to control disease.
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Avian reovirus (ARV) pathogens are found worldwide
[1-3] and their molecular characterization, using PCR
and nucleotide sequence analysis, have been described
[4-6]. Yet, only a limited number of genomic sequences
belonging mainly to the S- class, has been published.
These sequences have characterized strains isolated from
USA, Taiwan, Germany, Netherlands, Australia, Japan
and China [7,8]. Recently, σC protein sequences of some
Indian strains were submitted to the Genbank.* Correspondence: abdeljelil.ghram@pasteur.rns.tn
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distribution, and reproduction in any mediumParticles of ARV present two layers of capsid and 10
segments of double-stranded RNA [9]. Genomic segments
can be separated on polyacrylamide gel electrophoresis
into three different classes, based on size, named L (large),
M (medium) and S (small). They encode for at least
8 structural and four non-structural proteins [10,11].
Amongst the S-class segments of ARV, the segment S1
contains three open reading frames that are translated into
P10, P17 and σC proteins [10,11]. The protein P10 induces
cell-cell fusion [12,13] while P17 causes cellular protein
translation shutoff and cell cycle arrest [14,15]. The σC
protein plays a role for virus attachment [16] and as
apoptosis inducer [17]. It has been demonstrated that cell
entry of avian reovirus follows a caveolin-1-mediated andtral Ltd. This is an Open Access article distributed under the terms of the
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tivation of p38 MAPK and Src signaling pathways [18]. It
has also been suggested that it represents the target for
type-specific neutralizing antibodies. The σB protein,
encoded by the S3 gene [10,19], carries group-specific
neutralizing epitopes [20]. Recently, the ARV σA protein,
encoded by the S2 gene [16], has been identified as a
double-stranded RNA binding protein that may be involved
in interferon resistance [21]. Another viral protein, σNS
encoded by the S4 gene, has been reported as having a
single-stranded RNA binding activity [22,23].
This paper reports the analyses of the σC and part of the
σB encoding genes along with the nucleotide sequences of
15 ARV isolates, identified over a 12-year period. To the
best of our knowledge, this is the first report regarding the
genotypic classification of ARV in Tunisia and in Africa.
Because ARV are important poultry pathogens, causing
arthritis, chronic respiratory disease and malabsorption
syndrome, which result in considerable economic losses to
the poultry industry [24,25], better understanding their
pathogenicity is economically important.
Methods
Being the major laboratory doing diagnostic and re-
search for poultry diseases in Tunisia, samples from
different flocks and regions were sent to the laboratory,
by private and governmental veterinarians, for the diag-
nostic of major avian diseases. Fifteen ARV isolates were
identified from chickens with viral arthritis, malabsorp-
tion syndrome or other suspected symptoms. The flocks
were located in governments in the north (Bizerte, Ben
Arous and Nabeul), the center (Sousse, Monastir and
Mahdia) and the south (Sfax) of the country. ARV were
propagated in specific pathogen-free (SPF) embryon-
nated chicken eggs, followed in cultures of primary
chicken embryo fibroblast (CEF) or liver (CEL) cells [7].
The virus was detected when strong cytopathic effects
(CPE) were observed after 3 to 5 subcultures; virus
stocks were subsequently prepared in 75 cm2 flasks.
Once 70-80% CPE were developed, cell cultures were
frozen and thawed 3 times, then clarified with low cen-
trifugation at 3000rpm for 20min. Supernatants were
then conserved in aliquots at −80°C for later use. The
vaccine strain (Nobilis S1133) was propagated in CEF
cells and treated as described above. Viral RNA was
extracted from supernatants using Trizol (Gibco Brl) as
per the procedural modification described by Lee et al.
[26]. Briefly, 1ml of Trizol was incubated with 300 μl of
clarified supernatant for 5min, at room temperature.
RNA was then isolated with chloroform (Sigma-Aldrich,
France) and precipitated with isopropan-alcohol (Sigma-
Aldrich, France) overnight. Total RNA was used as a
template for RT-PCR reactions; non infected-cells and
Rnase free water were used as negative controls.Primers
Primers used for RT-PCR reactions (Table 1) were selected
according to the sequences of S1 and S3 segments from
available ARV sequences [4,19,27].
Reverse transcription (RT), PCR and double Nested PCR
(N-PCR)
A double N-PCR amplified the full length of the σC en-
coding gene. For the RT reactions, RNA was denatured
in the presence of S1C or S1G forward primers (50pmol)
and 1 μl RNasin (Promega) in a total volume of 11 μl,
for 10 min, and rapidly cooled on ice. Subsequently, 9 μl
RT mixture, containing 4 μl 5X first strand buffer
(Invitrogen), 2 μl DTT and 2 μl dNTP (10 mM)) were
added to each sample. After 2min incubation at 42°C,
1 μl superscript reverse transcriptase (Invitrogen) was
added to each tube. The RT was carried out at 42°C for
50 min. The cDNA amplification was performed in 10 μl
volume, containing 1,5 mM MgCl2, 1X PCR buffer (Invi-
trogen), 2,5U Taq DNA Polymerase (Invitrogen), 0,5 μM
of each primer (S1C and S1D, S1G and S1H) and 5 μl of
sample from the RT reaction. PCR reactions were sub-
jected to 35 cycles (denaturation for 1 min at 94°C,
annealing for 1 min at 55°C, extension for 2 min at
70°C) and one final extension cycle at 70°C for 10 min
for the amplification of the whole σC gene. For the N-
PCR, 5 μl of 1/10 or 1/100 of each RT-PCR product was
amplified using primer sets (S1E and S1F, S1I and S1H)
with the same components as for the PCR reaction.
Samples were subjected to 35 cycles (45s denaturation at
94°C, 1min annealing at 55°C and 1min extension at
70°C) with a one final extension at 70°C for 7 min.
For the σB gene, samples were treated as described
above. RT was performed using P1 primer and samples
were subjects to 35 cycles (denaturation for 5 min at
94°C, annealing for 30 s at 50°C and extension for 70s at
70°C) with a one final extension for 7 min at 70°C.
Analysis of amplified products
After completion of the PCR reactions, 10μl of reaction
mixtures were loaded onto a 2% agarose gel for 1 hour in
TAE buffer (90 mM Tris–HCl, 90 mM acetic acid, 2 mM
EDTA, pH 8,3), containing 5 μl/ml ethidium bromide, for
electrophoresis and subsequent visualization with ultravio-
let transilluminator. A DNA ladder of 100 bp was run as a
size marker.
Sequencing analysis
PCR products were used for direct sequencing using for-
ward and reverse primers to obtain the full length of σC
and part of σB encoding genes. Sequencing was done
three times using PCR products of the same isolate to
avoid cross contamination. The ABI Prism Big Dye
Terminator Cycle Sequencing Reaction kit (Applied
Table 1 RT-PCR primer sequences and expected PCR products
Designation Sequence (5’-3’) Gene Locationa PCR products (bp)
S1C ATTGAATTCTCTCTGTTATCTAACCTTG σC 446-472 738
S1D AAGGAATTCGTTGAGAACAGAAGTAGG σC 1183–1157
S1E TCTGAATTCATCCGCAGCGAAGAGAGGTG σC 630–658 342
S1F AGTGAATTCAGTATCGCCGTGCGCAG σB 971–943
S1G CCTGAATTCGTGACTGACTTAACGAAC 910–936 720
S1I ACGAATTCTTTCATTAGACATGGACC 1130–1156 520
S1H TAAGAATTCCCAGTACGGCGCCACA 1629–1603
P1 TAACATCTAGCTATTTG 67–83 627
P2 CAAGCATTACAGGGCCAGC 720-738
a Location according to Yin et al.[19] and Liu et al. [27,28].
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were run on polyacrylamide gel POP 7 in a four-capillary
Applied Biosystem Genetic Analyser. Nucleotide sequences
were aligned for comparison using “Clustal W” from Bio-
Edit Sequence Alignment Editor [29,30]. The sequences
were deposited in the Genbank database (see Table 2 for
the accession numbers of the nucleotide sequences).
Phylogenic analysis
The full length of the σC and only part of the σB gene
sequences were translated using the Bio-Edit program.
The phylogenetic tree, for either epidemiological or
phylogenic relationship studies, was constructed using
Splits Tree version 4.10 Software with the Neighbour-
Joining (NJ) method and bootstrap analysis (n=1000), to
determine the best fitting tree for each gene [34].
Results
Fifteen Tunisian ARV were isolated (Table 2) in SPF eggs,
CEF and/or CEL cell cultures. S1133 vaccine strain, used
as a control, was propagated in CEF cultures. Aliquots of
clarified freeze-thawed cell supernatants (4 or 5 passages)
were used for RNA extraction. Using primer pairs of S1C-
S1D, S1E-S1F, S1G-S1H, S1I-S1H for the σC gene and
P1-P2 for the σB gene, RNA extracts from all ARV isolates
as well as the S1133 strain was transcribed into cDNA and
amplified, producing fragments with expected sizes of 738,
342, 720, 500 and 672 bp, respectively. PCR products from
S1133 strain and the Tunisian isolates were obtained, indi-
cating that primer regions were conserved in our strains.
RNA extracted from non-infected cells and Rnase-free
water were used as negative controls and no DNA amp-
lification was observed, indicating that the amplified
viral DNA was specific and did not originate from
contamination.
Sequence analyses and phylogenic study
To gather information about the genetic classification of
the Tunisian isolates, different sequences of σC and σBencoded genes, from pathogenic and vaccine strains were
analysed. ARV sequences are labelled as submitted by our
laboratory or by others (Table 2) [4,7,27,28,31-33].
Alignment of nucleotides of the σC encoded gene of
all identified strains showed a close relationship with the
American S1133 and the English JR1 pathogenic strains
[33] (Table 2). Analyses of the nucleotide sequences
revealed that the Tunisian strains showed the same
sequences as the strain S1133, except for the 97.1 and
97.2 isolates. The first one showed a substitution of
Guanine with Adenine at the position 354. This muta-
tion was observed for all Chinese, Japanese and Indian
strains (pathogenic and vaccine ones) and the only
isolate from Canada. However, six of all American (2048,
1733, 138, 176, GA41560, MS42563-1), seven of all
Taiwanese (T6, 70505, 919, 601G, 601SI, R2/TW, 916)
and one of two Australian (SOM-4) pathogenic strains
showed the same mutation. Moreover, the 97.1 had the
same sequence as the only English pathogenic strain JR1,
except that the later shows a substitution of Guanine with
Thymine at the position 927. Multi-alignment of deduced
amino acid (AA) sequences revealed that the mutations at
positions 354 and 927 were synonyms; thus no differences
were found in the AA sequences between 97.1, S1133 and
JR1 strains (Figure 1a). For the second strain 97.2, a substi-
tution of Adenine with Guanine at position 355 of the σC
gene was observed. This mutation was at the first position
of the corresponding codon and induced the substitution
of the amino acid encoded (Figure 1a). Same mutation was
likewise detected for the German strain GEL13a98M and
the two American strains MS42563-1 and 42563–4. Never-
theless, at this position, three of German (GEL0597M,
GEL0397T, GEL0196T) and Dutch (NLA1396, NLI098M,
NLI196) strains and two Taiwanese strains (918, 1017–1)
showed one Cytosine. The two American strains GA40963
and GA41565, however, showed one Thymine at this
position.
Using S1133 as a reference strain, alignment of nu-
cleotide sequences of the σB encoded gene, showed
Table 2 Virus used in this study and sequences submitted to Genbank by us and others
Isolate Symptomsa Origin Yearb Genbank accession
number l
σC σB
S1133 V.A.c USA 1973 AF330703 U20642
2408 Mal.S.d USA 1983 AF204945 AF208038
1733 Mal.S. USA 1983 AF004857 AF004856
138 V.A. USA UNf AF218359 AF059721
176 V.A. USA UN AF218358 AF059720
42563-4 R.S.Se USA 2005 DQ872801.1 N.A.
GA41565 R.S.S. USA 2005 DQ872799.1 N.A.
GA41560 R.S.S. USA 2005 DQ872798.1 N.A.
GA 40973 RS..S USA 2005 DQ872797.1 N.A.
MS46523-1 R.S.S. USA 2005 ABJ09661.1 N.A.
GA40963 R.S.S. USA 2005 ABJ09657.1 N.A.
V.A.Vac Vaccineg USA 2006 EF122837 N.A.
AVS-B R.S.S. USA 2005 YP004226527 YP004226529
JR1 N.Ah England UN EF122836.1 N.A.
TU399 V.A. Tunisia 1998 HM751135 HM751120
TU430 V.A. Tunisia 1998 HM751137 HM751122
TU429 Mal.S. Tunisia 1998 HM751136 HM751121
TU435 V.A. Tunisia 1998 HM751138 HM751123
TU96 V.A. Tunisia 1999 HM751139 HM751124
TU97.1 V.A. Tunisia 1999 HM751140 HM751125
TU97.2 V.A Tunisia 1999 HM751141 HM751126
TU119 Unclear i Tunisia 1999 HM751142 HM751127
TU420 Unclear Tunisia 2000 HM751143 HM751128
TU87 Unclear Tunisia 2001 HM751144 HM751129
TU5 Mal.S. Tunisia 2002 HM751145 HM751130
TU71B1 Unclear Tunisia 2002 HM751146 HM751131
TU105B6 Mal.S. Tunisia 2002 HM751147 HM751132
TU360 Mal.S. Tunisia 2004 HM751148 HM751133
TU1390 Mal.S. Tunisia 2008 HM751149 HM751134
NLI1296M Mal.S Netherlands 1996 AF354230.1 N.A.
NLI0298M Mal.S Netherlands 1998 AF354229.1 N.A.
NLA1396T V.A. Netherlands 1996 AF354228.1 N.A.
99G Unclear China 1999 N.A. DQ415659
T-98 V.A. China 2006 ABK51295.1 ABK32526.1
C-98 V.A. China 2006 ABK51292.1 ABK32523.1
G-98 V.A. China 2006 ABG43119.1 ABK32524.1
HB06 V.A. China 2008 ACB11346.1 N.A.
OS161 Mal.S. Japan 1970 AF204946 AF301471
Fahey and Crawley R.D.k Canada 1954 ABI97289.1 N.A.
GEL13a98M Mal.S Germany 1998 AF354226.1 N.A.
GEL13b98M Mal.S Germany 1998 AF354227.1 N.A.
GEL12 98M Mal.S Germany 1998 AF354225.1 N.A.
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Table 2 Virus used in this study and sequences submitted to Genbank by us and others (Continued)
GEL06 97M Mal.S Germany 1997 AF354224.1 N.A.
GEL05 97M Mal.S Germany 1997 AF354223.1 N.A.
GEL03 97T V.A. Germany 1997 AF354222.1 N.A.
GEL01 96T V.A. Germany 1997 AF354221.1 N.A.
GEI09 97M Mal.S Germany 1997 AF354220.1 N.A.
GEI1097M Mal.S Germany 1997 AF354219.1 N.A.
K5 N.A. India 2008 EU681261.1 N.A.
820 N.A. India 2008 EU681260.1 N.A.
MKA N.A. India 2008 EU681259.1 N.A.
MS-4 N.A. India 2008 EU681258.1 N.A.
1884 N.A. India 2008 EU681257.1 N.A.
6-10 N.A India 2008 EU681256.1 N.A.
VA-1is V.A India 1983 EU681254 N.A
VA-1 Vaccine India 2008 EU681255.1 N.A.
Bareilly son-1 N.A. India 2008 HM015906.1 N.A.
Bareilly N.A. India 2008 FJ949087.1 N.A.
T6 R.D Taiwan 1970 AF204948 AF208036
750505 V.A. Taiwan 1986 AF204950 AF208035
919 Normal Taiwan 1992 AF204949 AF208034
601G V.A. Taiwan 1992 AF297217 AY008384
601SI VA. Taiwan 1992 AF204947 AF208037
R2/TW V.A. Taiwan 1992 AF297213 AF301472
918 Mal.S. Taiwan 1992 AF297215 AF301473
916 Mal.S. Taiwan 1992 AF297214 AY008383
1017-1 Mal.S. Taiwan 1992 AF297216 AF301474
a: Symptoms observed in infected chickens; b: year of isolation of the corresponding strain; c: viral arthritis; d: malabsorption syndrome; e: Runting-stunning
syndrome; f: year of isolation not known; g: sequences of vaccines derived from pathogenic strains S1133 or VA-1is; h: data not available; i: chicken's symptoms not
described; j: apparent healthy chickens; k: Respiratory disease; l: Accession Numbers submitted by us or according to Shapouri et al. [4]; Kant et al. [7]; Shmulevitz
et al. [31]; Liu et al. [27,28]; Zhang et al. [32]; Guo et al. [33].
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308, was observed only for TU430 and TU360 isolates.
The second substitution located at position 438, was
observed for strains TU429 and TU430 which were iso-
lated in 1998, for TU96 and TU119, isolated in 1999 and
for TU360, collected in 2004. Lastly, three substitutions
were observed at positions 467, 521 and 656 for all
Tunisian strains. Multi-alignment of these strains with
the most published ones indicated that the sequences of
their σB encoded gene are closely related to the Chinese
99G strain, which shows the same nucleotide sequence
as the three isolates (TU429, TU96, TU119). Deduced
AA sequences demonstrated that all the observed muta-
tions are non-synonymous and imply substitutions of
the corresponding AA (Figure 1b).
Phylogenic comparison of genotype clustering based
on nucleotide sequences of the σC gene of the Tunisian
isolates with published one, showed that they are closelyrelated to each other and can be classified in cluster I
with all Indian and Chinese strains as well as those iso-
lated from England, Japan and Canada. They remain
different from Australian and Dutch isolates, found only
in the clusters V and VI, respectively. The Taiwanese
isolates are more dispersed and evolved in at least 4
clusters. The isolates from Germany and America are
the most dispersed ones and grouped in 5 different clus-
ters and only one American strain 138 is placed in clus-
ter II (Table 2, Figure 2a) [7,8,27].
For the σB gene sequences, the phylogenic tree
showed that the Tunisian strains are relatively closer to
each other and can be classified in the same cluster I
with the only Japanese strain OS161, all Chinese and
four Taiwanese strains. The remainder Taiwanese strains
are classified in cluster II and III, respectively. However,
the American strains are dispersed in clusters I and III
(Table 2, Figure 2b).
Figure 1 (See legend on next page.)
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Figure 1 Multiple sequence alignment of σC (326 AA) (a) and part of σB proteins (b) (residue 67 to 153) of ARV. The predicted AA
sequences of σC and part of σB proteins of 15 Tunisian ARV isolates (TU339, TU429, TU430, TU435, TU96, TU97.1, TU97.2, TU119, TU420, TU87, TU5,
TU71B1, TU105B6, TU360 and TU1390) were aligned and compared to previously published sequences using 'Clustal W' from Bio-Edit Sequence
Alignment Editor [27,29]. Sequencing was done three times using PCR products of the same isolate to avoid cross contamination. AAs are
numbered up the sequences residues. AAs identical to the S1133 pathogenic strain sequence are indicated by dot. Genbank accession numbers
of the strains, either determined in this study or submitted by others, are cited in Table 2.
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ARV pathogenicity is very heterogeneous and ARV strains
are associated with disease conditions such as viral
arthritis (VA), tenosynovitis and Malabsorption Syndrome
(MAS). They are also isolated from chickens without any
clinical signs [35]. Although the relationship between
reovirus and tenosynovitis has been established, a causa-
tive role is less clear in MAS [36]. The characterization
and the classification of ARV might be important for the
epidemiology of MAS and VA for the choice of the appro-
priate vaccine in farms with ARV problems. Although
ARV infections still cause problems in poultry, the only
available ARV sequences are for strains from the USA,Figure 2 Phylogenic trees of the σC (a) and part of the σB (b) genes o
nucleotides sequences using splits tree phylogenic software (version 4.10)
was assessed by bootstrap analysis with 1.000 replications; only bootstrap v
proportional to the minimum number of nucleotide differences required to
scale bar is proportional to the phylogenic distance (Table 2).Canada, Taiwan, Australia, the Netherlands, Germany,
Japan, England and China. Recently, σC encoded gene
sequences from Indian isolates became available in
Genbank [7,8] (Table 2).
Genotyping of ARV using σC encoded gene revealed at
least 6 different genotypes [27], but correlations between
genotypes, pathogenic characteristics and serotype classifi-
cation have not been well established yet. A phylogenic
study using the σC encoded gene indicated that, despite
the close relationship with the first USA isolates belonging
to clusters I and II, those recently isolated from chickens
with Runting-Stuning Syndrome (RSS) showed dispersion
and were classified in the 3 different clusters III, IV and VIf Tunisian ARV strains. The trees were generated on the base of
with distance-based neighbour-joining (NJ). The reliability of the trees
alues of > 90% are shown. The length of the horizontal lines is
join nodes. The vertical lines are spacing branches and labels. The
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Australian and Dutch strains, classified in the clusters V
and VI, respectively. The first strains isolated from Taiwan
were classified in cluster I, whereas the more recent ones
were dispersed between the 3 clusters II, III, and V. Fur-
thermore, the German strains isolated during the last two
years are much more dispersed and classified into 5 clus-
ters. Finally, the trypsin-resistant strain JR1 is classified in
the cluster I [8,27,33].
Molecular characterization of the σC sequences of all
Tunisian ARV, isolated from different field conditions
over a twelve years period and compared to several pub-
lished strains, allowed their classification in one cluster.
However, no correlation could be established between
the σC gene sequences and the disease conditions in the
field. ARV were also isolated from apparently healthy
chickens, making their classification in a true lineage dif-
ficult as stated by Kant et al. [7].
The σC-encoding gene has evolved into six clusters,
while the other S-class genes have diverged into two to
four clusters [27]. It displayed features of the highest
level of sequence divergence and rapid evolution. There-
fore, this gene could be used as a genetic marker for the
classification of ARV isolates [27,28]. Such classification
in clusters is independent of determination of the 5' end,
the 3' end or the whole ORF of the σC gene. Further-
more, sequencing of a representative part of this gene
seems to be sufficient [7].
The major part of σC gene sequences of the Tunisian
isolates was closely related to the very well-known
American strain S1133. Only nucleotide sequences of
the 97.1 and 97.2 strains showed mutations at the posi-
tions 354 and 355, respectively. A relationship between
the 97.1 and JR1 strains is possible; however, data about
the σB gene sequence of the later is not yet published
for a possible gene comparison.
Analyses of the whole σB-encoding gene were per-
formed to allow rapid detection of ARV infections with
different Tunisian isolates. The constructed Phylogenic
trees showed in previous studies that the gene evolves
into 2–3 lineages [8,27]. Analyses of the published
sequences demonstrated that it evolves into 3 clusters,
results obtained when using sequences of the whole gene
or the representative sequence used in our work. Re-
cently, we performed a restriction fragment length poly-
morphism (RFLP) with two restriction enzymes that cut
in two sites among those containing mutations on our
amplicons (data no shown). PCR/RFLP can be a proced-
ure used for rapid characterization and differentiation of
Tunisian ARV isolates.
Mutations do exist in the σB gene sequences of Tunisian
strains, allowing their classification into 4 groups: a first
group containing the TU430 and TU360 isolates; a second
one with the TU429, TU96 and TU119 isolates; a thirdgroup containing the TU339, TU87, TU5, TU420,
TU105B6, TU1390, TU71B1, TU435 and TU97.1 isolates
and the fourth group with only the TU97.2 isolate. The
substitution at position 467 was observed for all ARV with
respect to the S1133 strain.
Sigma B protein was described as a high variable pro-
tein and possesses group-specific neutralizing epitopes
[37]. Alignment analysis of amino acids of part of the σB
protein showed that only the substitution at position
171 is silent, whereas all other mutations at positions
308, 438, 467, 521 and 656 are non-synonymous and
induced substitution of the corresponding translated AA
(Figure 1b). These mutations were also observed for the
Chinese isolate 99G and indicated a possible relationship
between the Tunisian and the Chinese ARVs. Unfortu-
nately, the σC gene sequence of the 99G isolate is not
available for comparison. For the Taiwanese strains, the
majority of nucleotide substitutions were silent because
they occur at the third position of the codons [27].
The σC protein, located on the surface of the outer
layer capsid, induces neutralizing antibody production
and is the determinant for ARV serotypes [16]. In previ-
ous studies, ARV strains were differentiated by virus
neutralization assays [38]. Serological classification of
ARV strains has not been successful because of high
cross-reactivity of the neutralizing antibodies [33]. Now-
adays, genotypic classification of ARV strains is per-
formed using RT-PCR in combination with phylogenic
analysis or other molecular techniques, such as RFLP
[7,26]. All phylogenic studies have classified ARV iso-
lates into various groups and lineages; however, meta-
analytically, there were no identical patterns. Such
results suggested that different ARV genome segments
may evolve in independent manner [27]. It is puzzling
that no correlation was found between genotypes, sero-
types and pathotypes, given detectable genetic differ-
ences of different ARV strains [7]. Divergences between
genotypes, serotypes and pathogenicity suggested the in-
volvement of multiple genes and proteins in serologic
and pathogenic determination [33]. It may also result
from high mutation rate of viral RNA and the possible
reassortment between 2 strains co-infecting the same
host [27,39]. Geographic characteristic conditions could
facilitate exchanges between segmented genomes within
small numbers of viral strains, which would result in less
genetic variation within a region [33].
Vaccination against reovirus infections generally
involves a live S1133 vaccine followed by an inactivated
vaccine containing strains 1733 and/or 2408, knowing to
be related to tenosynovitis and stunting syndrome
pathologic conditions and belonging to the same subtype
[40,41]. Although chickens were vaccinated, ARV patho-
gens still persist in Tunisian poultry. Serotyping studies
are therefore needed to further elucidate the antigenic
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Conclusion
In the present study, we characterize genetically avian
reovirus Tunisian strains isolated from commercial
chickens reared in different geographic areas, during a
12 year period. The classification of ARV could be rea-
lized using the σC gene, the most variable known gene
but other gene studies may provide additional informa-
tion. It was not possible, however, to correlate the geno-
type of isolated strains with neither a specific pathologic
conditions nor a geographic or temporal parameter. Al-
though the vaccination against ARV is used in farms,
the pathogens still persist in Tunisian poultry flocks.
Serotyping studies are underway to characterize the anti-
genic proprieties of these isolates, which will help adapt-
ing the vaccination program.
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